Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats

被引:18
作者
Brissot, P
Bolder, U
Schteingart, CD
Arnaud, J
Hofmann, AF
机构
[1] INSERM, U49, RENNES, FRANCE
[2] UNIV CALIF SAN DIEGO, DEPT MED, DIV GASTROENTEROL, LA JOLLA, CA 92093 USA
[3] UNIV HOSP, DEPT BIOCHEM, GRENOBLE, FRANCE
关键词
D O I
10.1002/hep.510250625
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In iron overload, non-transferrin-bound iron (NTBI) is found in plasma and is rapidly removed by hepatocytes. Some of this NTBI is excreted into bile. Biliary excretion of NTBI, in the form of an iron-deferiprone chelate, is greatly increased by deferiprone, an iron chelator. The aim of this study was to test whether biliary iron as such or as an iron deferiprone chelate (both originating from plasma NTBI) is absorbed from the intestine and re-secreted into bile. In healthy biliary fistula (donor) rats, biliary Fe-55 originating from plasma NTBI was obtained by injecting Fe citrate (to saturate transferrin) followed by Fe-55. This biliary Fe-55 was infused into the duodenum of (recipient) rats whose transferrin was saturated or unsaturated. Similar experiments were performed using iron overloaded (donor) rats given deferiprone, followed by infusion of the biliary Fe-55-deferiprone chelate into iron-overloaded (recipient) rats. The results show that in healthy (recipient) rats, duodenal infusion of Fe-55 from NTBI was followed by increased plasma Fe-55 when transferrin was unsaturated, or by biliary excretion of Fe-55 when transferrin was saturated, indicating intestinal absorption of Fe-55. In iron-overloaded rats, neither plasma nor bile became radioactive, indicating no intestinal absorption of iron from the deferiprone chelate. We conclude that biliary iron, originating from NTBI, is absorbed from the intestine, and undergoes enterohepatic circulation if transferrin is saturated. In iron-overloaded rats, biliary iron orignating from plasma NTBI and present as an iron deferiprone chelate in bile is not absorbed.
引用
收藏
页码:1457 / 1461
页数:5
相关论文
共 31 条
[21]  
KONTOGHIORGHES GJ, 1987, LANCET, V1, P1294
[22]   LONG-TERM TRIAL WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) [J].
KONTOGHIORGHES, GJ ;
BARTLETT, AN ;
HOFFBRAND, AV ;
GODDARD, JG ;
SHEPPARD, L ;
BARR, J ;
NORTEY, P .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) :295-300
[23]   BILIARY-EXCRETION OF IRON FROM HEPATOCYTE LYSOSOMES IN THE RAT - A MAJOR EXCRETORY PATHWAY IN EXPERIMENTAL IRON OVERLOAD [J].
LESAGE, GD ;
KOST, LJ ;
BARHAM, SS ;
LARUSSO, NF .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (01) :90-97
[24]   ACUTE INFUSIONS OF BILE-SALTS INCREASE BILIARY-EXCRETION OF IRON IN IRON-LOADED RATS [J].
LEVY, P ;
DUMONT, M ;
BRISSOT, P ;
LETREUT, A ;
FAVIER, A ;
DEUGNIER, Y ;
ERLINGER, S .
GASTROENTEROLOGY, 1991, 101 (06) :1673-1679
[25]   KINETIC EVALUATION OF FREE MALONDIALDEHYDE AND ENZYME LEAKAGE AS INDEXES OF IRON DAMAGE IN RAT HEPATOCYTE CULTURES - INVOLVEMENT OF FREE-RADICALS [J].
MOREL, I ;
LESCOAT, G ;
CILLARD, J ;
PASDELOUP, N ;
BRISSOT, P ;
CILLARD, P .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (11) :1647-1655
[26]   IRON-CHELATION THERAPY WITH ORAL DEFERIPRONE IN PATIENTS WITH THALASSEMIA MAJOR [J].
OLIVIERI, NF ;
BRITTENHAM, GM ;
MATSUI, D ;
BERKOVITCH, M ;
BLENDIS, LM ;
CAMERON, RG ;
MCCLELLAND, RA ;
LIU, PP ;
TEMPLETON, DM ;
KOREN, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :918-922
[27]   COMPARISON OF ORAL IRON CHELATOR L1 AND DESFERRIOXAMINE IN IRON-LOADED PATIENTS [J].
OLIVIERI, NF ;
KOREN, G ;
HERMANN, C ;
BENTUR, Y ;
CHUNG, D ;
KLEIN, J ;
STLOUIS, P ;
FREEDMAN, MH ;
MCCLELLAND, RA ;
TEMPLETON, DM .
LANCET, 1990, 336 (8726) :1275-1279
[28]   BILIARY-EXCRETION OF IRON IN HEALTHY MAN AND IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER [J].
RAEDSCH, R ;
STIEHL, A ;
WALKER, S ;
THEILMANN, L ;
KOMMERELL, B ;
WALDHERR, R ;
SENN, M .
CLINICA CHIMICA ACTA, 1990, 193 (1-2) :49-54
[29]  
TSE FLS, 1982, J PHARMACOL METHOD, V7, P139, DOI 10.1016/0160-5402(82)90026-2
[30]  
WRIGHT TL, 1986, J BIOL CHEM, V261, P909